Email updates

Keep up to date with the latest news and content from Behavioral and Brain Functions and BioMed Central.

Open Access Research

Interaction between Serotonin Transporter and Serotonin Receptor 1 B genes polymorphisms may be associated with antisocial alcoholism

Tzu-Yun Wang127, Sheng-Yu Lee145, Shiou-Lan Chen5, Yun-Hsuan Chang35, Shih-Heng Chen5, Chun-Hsien Chu5, San-Yuan Huang6, Nian-Sheng Tzeng6, Chen-Lin Wang5, I Hui Lee15, Tzung Lieh Yeh125, Yen Kuang Yang125 and Ru-Band Lu12345*

Author Affiliations

1 Department of Psychiatry, College of Medicine, National Cheng Kung University, Tainan, Taiwan

2 Institute of Behavioral Medicine, National Cheng Kung University, Tainan, Taiwan

3 Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan

4 Addiction Research Center, College of Medicine, National Cheng Kung University, Tainan, Taiwan

5 Department of Psychiatry, National Cheng Kung University Hospital, Tainan, Taiwan

6 Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

7 Department of Psychiatry, Tainan Hospital, Department of Health, Executive Yuan, Tainan, Taiwan

For all author emails, please log on.

Behavioral and Brain Functions 2012, 8:18  doi:10.1186/1744-9081-8-18


The electronic version of this article is the complete one and can be found online at: http://www.behavioralandbrainfunctions.com/content/8/1/18


Received:20 November 2011
Accepted:2 May 2012
Published:2 May 2012

© 2012 Wang et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Several studies have hypothesized that genes regulating the components of the serotonin system, including serotonin transporter (5-HTTLPR) and serotonin 1 B receptor (5-HT1B), may be associated with alcoholism, but their results are contradictory because of alcoholism’s heterogeneity. Therefore, we examined whether the 5-HTTLPR gene and 5-HT1B gene G861C polymorphism are susceptibility factors for a specific subtype of alcoholism, antisocial alcoholism in Han Chinese in Taiwan.

Methods

We recruited 273 Han Chinese male inmates with antisocial personality disorder (ASPD) [antisocial alcoholism (AS-ALC) group (n = 120) and antisocial non-alcoholism (AS-N-ALC) group (n = 153)] and 191 healthy male controls from the community. Genotyping was done using PCR-RFLP.

Results

There were no significant differences in the genotypic frequency of the 5-HT1B G861C polymorphism between the 3 groups. Although AS-ALC group members more frequently carried the 5-HTTLPR S/S, S/LG, and LG/LG genotypes than controls, the difference became non-significant after controlling for the covarying effects of age. However, the 5-HTTLPR S/S, S/LG, and LG/LG genotypes may have interacted with the 5-HT1B G861C C/C polymorphism and increased the risk of becoming antisocial alcoholism.

Conclusion

Our study suggests that neither the 5-HTTLPR gene nor the 5-HT1B G861C polymorphism alone is a risk factor for antisocial alcoholism in Taiwan’s Han Chinese population, but that the interaction between both genes may increase susceptibility to antisocial alcoholism.

Keywords:
Antisocial alcoholism; Serotonin; Serotonin transporter gene; 5-HT1B gene

Background

Alcoholism (also: alcohol dependence) is a complex, heterogeneous disorder that is influenced by multiple genes as well as sociocultural factors [1,2]. Twin studies have shown that genetic factors account for about 50-60% of the overall variance in alcoholism [3-5]. Many candidate genes have been studied; however, the results are controversial. Therefore, to reduce the heterogeneity of alcoholism by proper subtyping is important. In addition, a gene-to-gene interaction approach may be more revealing than a single-gene approach for studying alcoholism. By using appropriate subtypes of alcoholism and the gene-to gene interaction approach, the results may be more conclusive.

Cloninger (1987) identified two subtypes of alcoholism. Type I alcoholism is characterized by late onset, more psychological dependence, and anxious/depressed personality traits. Individuals with type II alcoholism are characterized by early onset, a higher familial risk for alcoholism, and antisocial personality traits [1]. We previously subdivided alcoholism into three categories: pure, anxious/depressive, and antisocial (AS) [6]. We showed that antisocial alcoholism (AS-ALC; alcoholism comorbid with antisocial personality disorder), which overlaps to some extent with Cloninger’s type II alcoholism, have a strong genetic predisposition to alcoholism and different genetic polymorphisms than do other subtypes of alcoholism. The protective effect of the ADH1B*2 allele against alcoholism vanished in antisocial alcoholics [6], and the protective effect of the ALDH2*2 allele might disappear in individuals with antisocial personality disorder (ASPD) and carrying the MAOA-uVNTR 4-repeat allele [7]. Antisocial alcoholics had higher novelty-seeking scores with an interaction between the DRD2 TaqI A1 (A1A1 or A1/A2) and 5-HTTLPR S/S genotype [8]. Moreover, antisocial alcoholics had different polymorphisms of the serotonin (5-HT) receptor 1B A-161T from other subtypes of alcoholics [9]. All the evidence supports the typology of alcoholism and the particular genetic vulnerability of antisocial alcoholics.

Numerous studies have reported reduced brain serotonin (5-hydroxytryptamine, 5-HT) function in patients who are similar to antisocial alcoholics. Lower cerebrospinal fluid concentration of the 5-HT metabolite 5-HIAA (5-hydroxyindoleacetic acid) has been found in early-onset antisocial alcoholics [10], impulsive alcoholic criminals [11,12], and alcoholic fire setters [13,14]. In addition, the variation of the central 5-HT system has been shown to modulate alcohol consumption and may contribute to the risk of alcoholism [15-17]. Genes encoding the 5-HTT gene (the serotonin transporter protein; genetic locus SLC6A4) and 5-HT receptor, which may cause different levels of activity of 5-HTT, have been examined as candidate genes for the risk of alcoholism. The polymorphism of the 5-HTT-linked promoter region (5-HTTLPR), which contains an insertion-deletion of two 22-bp repeats in a region of the promoter with multiple 22- to 23-bp repeats [18], affects the expression of serotonin transporter [19]. In vitro study, the short variant (S-allele) of the 5-HTTLPR displayed reduced transcriptional activity [19] as well as decreased serotonin transporter expression and serotonin uptake in lymphoblast cell lines [18]. 5-HTTLPR polymorphisms were also correlated to the function of serotonin transporter both in vivo imaging study [20] and in postmortem brain study [21]. Human SPECT study showed that homozygous carriers of the long allele (L/L) had an increase in the availability of raphe serotonin transporter [20]. Serotonin transporter mRNA levels in subjects with S/L and S/S genotypes were also lower than in subjects with the L/L genotype in postmortem brain study [21]. Although the S allele has been linked to a risk of alcoholism [22,23] and to antisocial alcoholics or type II alcoholics [24-26], this link is still controversial [20,27,28]. In addition to the long and short alleles, other subtypes of the L allele have been described [29]. The long variant with an adenosine at single nucleotide polymorphism (SNP) rs25531 (LA) has been reported to have higher activity than the long variant with a guanine at rs25531 (LG) [30,31]. Furthermore, other uncommon alleles that are longer than the L variant were found in several studies [29,32-35]. The extra-long allele or “novel allelic variant” were called XL variants with 15, 18,19, 20 or 22 repeats with unknown function [29,32-35]. Hence, the past dichotomous classification of 5HTTLPR into S and L allele may not be sufficient and the association between the tri-allelic 5-HTTLPR polymorphism (SLALG) and the risk of alcoholism or antisocial alcoholism remains unknown.

The serotonin 1B receptors (5-HT1B) are located on presynaptic and postsynaptic terminals and function as both autoreceptors and heteroreceptors that mediate the release of serotonin [36]. The 5-HT1B gene has been associated with alcohol intake and aggression in animal and human studies. An alcohol preference locus has been mapped in mice to the region where 5-HT1B is located [37]. 5-HT1B receptor knockout mice were found to have increased aggressive behavior [38] and increased spontaneous alcohol consumption [39]. In human studies, of 16 reported polymorphisms of 5-HT1B, the results of association studies that used the G861C polymorphism remain inconsistent [40]. Some studies associated polymorphisms of 5-HT1B G861C with alcoholism [41] or antisocial alcoholism [42]. People with the 5-HT1B 861C allele also had 20% fewer 5-HT1B binding sites in the prefrontal cortex, which was the same as the alcoholism group [43,44]. However, subsequent studies did not confirm the association [45-47]. The heterogeneity of alcoholism, as well as different populations and ethnicities, may cause the discrepancy.

The prevalence rate of ASPD and antisocial behaviors in individuals with alcohol use disorders ranges from 20% to 33% [48-50]. Because of their high comorbidity, most studies have not distinguished the effects of ASPD from those of alcoholism in Western populations [51]. Being able to specify whether the genes were involved in pure ASPD (ASPD not comorbid with alcoholism (AS-N-ALC)) or AS-ALC, or both, may clarify the nature of these disorders and elucidate whether past genetic associations with AS-ALC were merely contributed by ASPD.

The aims of current study is to (1) investigate whether the tri-allelic 5-HTTLPR polymorphism and 5-HT1B G861C polymorphism are associated with AS-ALC in the Han Chinese population in Taiwan, and (2) assess the serotonergic genetic interaction between 5-HTTLPR and 5-HT1B G861C polymorphisms and antisocial alcoholism.

Methods

Participants and clinical assessments

This study was approved by the Institutional Review Boards for the Protection of Human Subjects at the Tri-Service General Hospital and National Cheng Kung University Hospital. Because of the low prevalence (0.1%) of ASPD in Han Chinese in Taiwan [52], it is difficult to recruit study participants with ASPD from clinics or from the community. Instead, we recruited 273 Han Chinese men with ASPD from a prison in Taipei (northern Taiwan) (n = 173) and a prison in Tainan (southern Taiwan) (n = 100). The research protocol was reviewed and approved by the Taiwan Ministry of Justice, which permitted us to collect blood samples from the participants. The procedures were fully explained to each participant before they gave written informed consent; however, there were no advocates for the inmates present when they were asked to sign the consent form. Participants were told that they were free to drop out of or to join the study at any time. We offered several compensatory benefits: 1) a free physical examination, 2) liver and renal function tests, and 3) and free treatment or assistance in transferring those with psychiatric or physical illnesses to hospitals. Each participant was initially evaluated by an attending psychiatrist and then interviewed by a psychologist well-trained in using the DSM-IV and the Modified Chinese Version of the Modified Schedule of Affective Disorder and Schizophrenia-Life Time (SADS-L) [53,54]. The inter-rater reliability of the Chinese version of the modified SADS-L was good with the kappa values range from 0.71 to 1.00 in several major mental illness [54]. The SADS-L was also found to be adequate for diagnosing ASPD with or without alcoholism [6,55-57]. Participants with major mental illnesses including schizophrenia, bipolar disorder, multiple substance abuse, or other organic mental disorders, and those who refused to participate (< 10%) were excluded from the study. None of the participants was taking any kind of medication. All who met the criteria for a diagnosis of antisocial personality disorder with or without alcoholism were assigned to the AS-ALC group) (n = 120) or the AS-N-ALC group (n = 153), respectively.

The healthy control group included 191 male volunteers recruited from the community. The Chinese version of the SADS-L was used to screen their psychiatric conditions. All controls were free of present and past major and minor mental illness (affective disorder, schizophrenia, anxiety disorder, personality disorder, alcohol abuse and dependence, and illegal substance use disorder), and none had a family history of psychiatric disorders among their first-degree relatives.

Blood samples and genotyping for 5-HTTLPR and 5-HT1B G861C polymorphisms

Twenty milliliters of blood was drawn from each participant, and standard methods were used to extract genomic DNA from the leukocytes. The genotypes of 5-HTTLPR functional polymorphisms were genotyped using polymerase chain reaction plus restriction fragment length polymorphism (PCR-RFLP) analysis [18]. The A/G SNP of the L allele were determined using a modified protocol [58]. The G861C polymorphism of the 5-HT1B gene was genotyped using a modified protocol [42].

Statistical analyses

One-way analysis of variance (ANOVA) and the Bonferroni Post Hoc Test were used to determine the mean age differences between the subgroups. The difference in genotype frequency of 5-HTTLPR and 5-HT1B G861C polymorphisms between three groups was calculated using the Pearson χ2 test (2-tailed). The 5-HTTLPR polymorphisms in AS-ALC and AS-N-ALC groups were further stratified by the 5-HT1B G861C polymorphism using the χ2 tests. Logistic regression analysis was used to examine the main effect and gene-to-gene interaction of the 5-HTTLPR and 5-HT1B G861C polymorphisms for the risk of antisocial alcoholism. Both the SA and the SG alleles were recorded as the S allele because there is no functional difference in the SNPs [59]. Because past studies found that S and LG carrier had lower function and expression of serotonin transporter [18-20,60], we divided the 5-HTTLPR polymorphisms into 2 groups, low-functional (S/SS/LGLG/LG) and high-functional (S/LALG/LALA/LAS/XLLA/XLLG/XL), for data analysis. There was only 8 participants carried the LALA genotype in our study, so we did not separate the homozygous LA carries from heterozygous LA carriers into another group. SPSS for Windows 17.0 (SPSS Inc., Chicago, IL, USA) was used for all statistical analyses.

The power estimation was calculated using G-power 3.1 software [61,62]. Our total sample size (n = 464) had a power of 0.58 to detect a small effect (effect size = 0.1), of 0.99 to detect a medium effect (effect size = 0.3), and of 1.00 to detect a large effect (effect size = 0.5) of genotype distributions.

Results

Healthy controls were significantly older than those in the AS-ALC (P = 0.004) and AS-N-ALC groups (P = 0.009; mean age: F = 6.87; df = 2, 461 (Table 1). A Bonferroni post hoc test did not show a significant age difference between the AS-ALC and AS-N-ALC groups.

Table 1. Demographic data

Genotype distributions of 5-HTTLPR and 5-HT1B G861C were in Hardy-Weinberg equilibrium (5-HTTLPR: P = 0.75 in AS-ALC and P = 0.22 in AS-N-ALC; 5-HT1B G861C: P = 0.07 in AS-ALC and P = 0.72 in AS-N-ALC). The distribution of the 5-HTTLPR and 5-HT1B G861C genotypes was not significantly different between the three groups (Table 2). However, there was a higher frequency of the low-functional 5-HTTLPR polymorphism (S/S, S/LG, LG/LG) in the AS-ALC group than in the control group (Table 2). After stratifying the 5-HTTLPR polymorphisms with the 5-HT1B G861C polymorphism, a significant difference in the frequency of 5-HTTLPR polymorphisms was found after controlling for the 5-HT1B G861CC/C genotype for both AS-ALC versus controls and AS-ALC versus AS-N-ALC (Table 3). A logistic regression analysis, done to control the possible covarying effect of age, showed that the 5-HTTLPR and 5-HT1B G861C genotypes were not significantly different between the AS-ALC and control groups or the AS-ALC and the AS-N-ALC groups (Table 4). However, the regression did reveal a significant interaction between the 5-HTTLPR and 5-HT1B G861C genes. Compared with AS-N-ALC and control groups, the interaction between the 5-HTTLPR low-functional group (S/S, S/LG, LG/LG genotype) and the 5-HT1B G861C C/C genotype may increase the risk of becoming an antisocial alcoholic (P = 0.04, odds ratio (OR) = 6.22 and 5.76, respectively) (Table 4).

Table 2. Genotype distribution and frequency of the5HTTLPRand5HT1B G861Cpolymorphism

Table 3. 5HTTLPRgenotype frequency after stratification of5HT1B G861Cgenotype

Table 4. Logistic regression analysis of5HTTLPRgene and5HT1Breceptor geneG861Cpolymorphism and their interaction for the risk of antisocial alcoholism (AS-ALC)

Discussion

We found that interaction between the 5-HTTLPRS/SS/LGLG/LG genotypes and the 5-HT1B G861C C/C genotypes was associated with the AS-ALC group compared with the control and AS-N-ALC groups. Unlike past studies [24-26,43], we did not find an association between the 5-HTTLPR or the 5-HT1B G861C polymorphisms with AS-ALC. Although the AS-ALC group seemed to have a higher frequency of the 5-HTTLPRS/SS/LGLG/LG genotype than did the control group, when the effect of age was controlled by logistic regression, the difference was not significant.

The interaction between the 5-HTTLPRS/SS/LGLG/LG and the 5-HT1B G861C C/C genotypes may result in reduced brain serotonin function. Because patients with the 5-HT1B 861 C allele were found with fewer 5-HT1B binding sites in the prefrontal cortex [43,44] and the 5-HTTLPRS/SS/LGLG/LG was the low-functional group [30,31], our results imply that only the combined effect of serotonergic dysfunction from the studied genes, but not from individual genes, may be associated with risk for antisocial alcoholism. Several other reasons may also account for our positive finding. First, past studies compared the 5-HTTLPR polymorphism between antisocial alcoholics and healthy (without ASPD and non-alcoholics) controls. Because ASPD has been linked to the 5-HTTLPR polymorphism [63-65], we tried to control for the confounding effect of ASPD by comparing antisocial alcoholics with healthy controls and antisocial non-alcoholics. Second, our healthy control group belonged to a super-control group that excluded any other major or minor mental illness, while in other studies [25,26], the authors included only individuals from unscreened community controls and no antisocial non-alcoholics. Moreover, we used a tri-allelic functional 5-HTTLPR polymorphism instead of a bi-allelic polymorphism. All these factors may have caused results different from those of other reports.

We found no association between antisocial alcoholism and the 5-HT1B G861C polymorphism. A previous study [43] showed that the frequencies of the 5HT1B 861 C allele varied widely among different ethnic groups, ranging from 20% in African-Americans to 36% in Hispanics and 42% in Asians. In our current study, the frequency of the 5-HT1B C allele (48.9% in the control group, 49.6% in the AS-ALC group, and 47.1% in the AS-N-ALC group) was higher than in previous reports. We also added an AS-N-ALC group to decrease the effect of ASPD. Different populations and ethnicities may also partially explain our different results.

Our past study [66] showed that antisocial alcoholics and antisocial non-alcoholics shared a similar genetic vulnerability of dopamine-related genes, which was different from healthy controls. However, in the present study, we did not find the same distributions of the 5-HTTLPR and 5-HT1B genes in the three groups. It seems that the antisocial non-alcoholics and healthy controls had a similar genotype distribution of these serotonin-related genes, one different from that of the antisocial alcoholics. We may speculate that other serotonin-related genes have the same distribution between individuals with ASPD and the general population. In addition, serotonin may modulate the reinforcement processes, possibly through complex interactions with the mesolimbic dopamine system [60,67] and the regulatory functions of several serotonin receptor subtypes, including 5-HT1B receptor [68-70]. The interaction of the dopaminergic and serotonergic neurotransmitter systems in the nucleus accumbens and the ventral striatum is thought to be critical in addiction [60,70,71]. Furthermore, enzymes involved in dopamine metabolism will also metabolize serotonin. Serotonin is initially metabolized to 5-hydroxyindole-3-acetaldehyde (5-HIAL) by monoamine oxidase (MAO) [72], and then oxidized to 5-hydroxyindole-3-acetic acid (5-HIAA) by aldehyde dehydrogenase (ALDH) [73]. We have reported [74] that the dopamine D2 receptor gene interacted with the 5-HTTLPR gene in antisocial alcoholics with specific personality traits. Hence, additional studies to explore the associations among the 5-HTTLPR, the 5-HT1B gene, 5-HT metabolic enzyme-related genes, and dopamine-related genes will be required to study the pathogenesis of AS-ALC.

Our study has several limitations. First, the study populations in the AS-ALC and AS-N-ALC groups were small. In addition, the cell size with the significant finding was also small, which may cause the risk of false positive results. Larger study populations are needed. Second, there were few participants with the 5-HTTLPRLA/LA genotype, and about 3.8% with the 5-HTTLPR XL allele, which is different from other ethnic groups [30]. It may be feasible to divide those with the 5-HTTLPRS/LALG/LALA/LAS/XLLA/XLLG/XL genotypes into a high-functional group and those with the S/SS/LGLG/LG genotypes into a low-functional group for statistical analysis according to past study results [18-20,60]. Although the function of the 5-HTTLPR XL allele remains unknown, one study had speculated that it may function as an L allele [75]. However, additional study will be required to test its function since a significant proportion of Han Chinese carry this allele [75]. Finally, it is very likely that individuals with ASPD may belong to a specific group since members of both the AS-ALC and AS-N-ALC groups were all recruited from jail, which caused sampling biases. In addition, we used controls without any past psychiatric history from the community. Regardless of alcoholism, the inmate participants with ASPD were substantially different from the healthy community participants [75]. It is necessary to be aware of the possibility of false-positive results when comparing these phenotypes with super-normal controls42.

Our results supported the notion that antisocial alcoholism is associated with the interaction between the 5-HTTLPR and 5-HT1B G861 polymorphisms. Additional studies to examine the 5-HTTLPR and 5HT1B G861C gene polymorphisms and their interaction effects with the dopaminergic gene in antisocial alcoholism are required.

Patient consent

Obtained.

Ethical approval

This study was approved by the Institutional Review Boards for the Protection of Human Subjects at the Tri-Service General Hospital and National Cheng Kung University Hospital.

Abbreviations

5-HTTLPR, Serotonin transporter; 5-HT1B, Serotonin 1 B receptor; ASPD, Antisocial personality disorder; AS-ALC, Antisocial alcoholism; AS-N-ALC, Antisocial non-alcoholism.

Competing interests

The authors declare no conflict of interests.

Authors’ contributions

The author, TYW wrote the first draft of this manuscript and designed this study with the author RBL. The authors, SYL and Y-HC managed the statistical analyses. The authors, SLC, SHC, CHC and CLC managed the lab work. The authors, TYW, SYH, NST, IHL, TLY, YKY and RBL managed the patients recruitment. All authors read and approved the final manuscript.

Acknowledgments

This study was supported in part by grants, NSC 95-2314-B-006-114-MY3 and NSC-98-2314-B-006-022-MY3 (to R.B.L.) from the National Science Council, Taiwan, and a grant NHRI-EX90-8939BP from National Health Research Institute as well as by a grant from the National Cheng Kung University Project to Promote Academic Excellence and Develop World-Class Research Centers (to R.B.L.). However, the above institutions had no further role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the paper for publication.

References

  1. Cloninger CR: Neurogenetic adaptive mechanisms in alcoholism.

    Science 1987, 236:410-416. PubMed Abstract | Publisher Full Text OpenURL

  2. Edenberg HJ, Foroud T: The genetics of alcoholism: identifying specific genes through family studies.

    Addict Biol 2006, 11:386-396. PubMed Abstract | Publisher Full Text OpenURL

  3. Kendler KS, Heath AC, Neale MC, Kessler RC, Eaves LJ: A population-based twin study of alcoholism in women.

    JAMA 1992, 268:1877-1882. PubMed Abstract | Publisher Full Text OpenURL

  4. Heath AC, Bucholz KK, Madden PA, Dinwiddie SH, Slutske WS, Bierut LJ, Statham DJ, Dunne MP, Whitfield JB, Martin NG: Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men.

    Psychol Med 1997, 27:1381-1396. PubMed Abstract | Publisher Full Text OpenURL

  5. Kendler KS, Prescott CA, Neale MC, Pedersen NL: Temperance board registration for alcohol abuse in a national sample of Swedish male twins, born 1902 to 1949.

    Arch Gen Psychiatry 1997, 54:178-184. PubMed Abstract | Publisher Full Text OpenURL

  6. Lu RB, Ko HC, Lee JF, Lin WW, Huang SY, Wang TJ, Wu YS, Lu TE, Chou YH: No alcoholism-protection effects of ADH1B*2 allele in antisocial alcoholics among Han Chinese in Taiwan.

    Alcohol Clin Exp Res 2005, 29:2101-2107. PubMed Abstract | Publisher Full Text OpenURL

  7. Lee SY, Hahn CY, Lee JF, Chen SL, Chen SH, Yeh TL, Kuo PH, Lee IH, Yang YK, Huang SY, et al.: MAOA-uVNTR polymorphism may modify the protective effect of ALDH2 gene against alcohol dependence in antisocial personality disorder.

    Alcohol Clin Exp Res 2009, 33:985-990. PubMed Abstract | Publisher Full Text OpenURL

  8. Wu CY, Wu YS, Lee JF, Huang SY, Yu L, Ko HC, Lu RB: The association between DRD2/ANKK1, 5-HTTLPR gene, and specific personality trait on antisocial alcoholism among Han Chinese in Taiwan.

    Am J Med Genet B Neuropsychiatr Genet 2008, 147B:447-453. PubMed Abstract | Publisher Full Text OpenURL

  9. Lee SY, Lin WW, Huang SY, Kuo PH, Wang CL, Wu PL, Chen SL, Wu JY, Ko HC, Lu RB: The relationship between serotonin receptor 1B polymorphisms A-161T and alcohol dependence.

    Alcohol Clin Exp Res 2009, 33:1589-1595. PubMed Abstract | Publisher Full Text OpenURL

  10. Fils-Aime ML, Eckardt MJ, George DT, Brown GL, Mefford I, Linnoila M: Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics.

    Arch Gen Psychiatry 1996, 53:211-216. PubMed Abstract | Publisher Full Text OpenURL

  11. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK: Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior.

    Life Sci 1983, 33:2609-2614. PubMed Abstract | Publisher Full Text OpenURL

  12. Linnoila M, De Jong J, Virkkunen M: Family history of alcoholism in violent offenders and impulsive fire setters.

    Arch Gen Psychiatry 1989, 46:613-616. PubMed Abstract | Publisher Full Text OpenURL

  13. Virkkunen M, Nuutila A, Goodwin FK, Linnoila M: Cerebrospinal fluid monoamine metabolite levels in male arsonists.

    Arch Gen Psychiatry 1987, 44:241-247. PubMed Abstract | Publisher Full Text OpenURL

  14. Virkkunen M, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C, Bissette G, Kalogeras K, Karonen SL, Linnoila M: CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers.

    Arch Gen Psychiatry 1994, 51:20-27. PubMed Abstract | Publisher Full Text OpenURL

  15. Kranzler HR, Anton RF: Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism.

    J Consult Clin Psychol 1994, 62:1116-1126. PubMed Abstract | Publisher Full Text OpenURL

  16. Sellers EM, Higgins GA, Sobell MB: 5-HT and alcohol abuse.

    Trends Pharmacol Sci 1992, 13:69-75. PubMed Abstract OpenURL

  17. LeMarquand D, Pihl RO, Benkelfat C: Serotonin and alcohol intake, abuse, and dependence: findings of animal studies.

    Biol Psychiatry 1994, 36:395-421. PubMed Abstract | Publisher Full Text OpenURL

  18. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.

    Science 1996, 274:1527-1531. PubMed Abstract | Publisher Full Text OpenURL

  19. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP: Allelic variation of human serotonin transporter gene expression.

    J Neurochem 1996, 66:2621-2624. PubMed Abstract | Publisher Full Text OpenURL

  20. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D, Linnoila M, Weinberger DR: A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.

    Biol Psychiatry 2000, 47:643-649. PubMed Abstract | Publisher Full Text OpenURL

  21. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DelProposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH: Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels.

    Am J Psychiatry 1998, 155:207-213. PubMed Abstract | Publisher Full Text OpenURL

  22. McHugh RK, Hofmann SG, Asnaani A, Sawyer AT, Otto MW: The serotonin transporter gene and risk for alcohol dependence: a meta-analytic review.

    Drug Alcohol Depend 108:1-6. OpenURL

  23. Feinn R, Nellissery M, Kranzler HR: Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence.

    Am J Med Genet B Neuropsychiatr Genet 2005, 133B:79-84. PubMed Abstract | Publisher Full Text OpenURL

  24. Parsian A, Cloninger CR: Serotonergic pathway genes and subtypes of alcoholism: association studies.

    Psychiatr Genet 2001, 11:89-94. PubMed Abstract | Publisher Full Text OpenURL

  25. Hallikainen T, Saito T, Lachman HM, Volavka J, Pohjalainen T, Ryynanen OP, Kauhanen J, Syvalahti E, Hietala J, Tiihonen J: Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior.

    Mol Psychiatry 1999, 4:385-388. PubMed Abstract | Publisher Full Text OpenURL

  26. Sander T, Harms H, Dufeu P, Kuhn S, Hoehe M, Lesch KP, Rommelspacher H, Schmidt LG: Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder.

    Biol Psychiatry 1998, 43:908-912. PubMed Abstract | Publisher Full Text OpenURL

  27. Ishiguro H, Saito T, Akazawa S, Mitushio H, Tada K, Enomoto M, Mifune H, Toru M, Shibuya H, Arinami T: Association between drinking-related antisocial behavior and a polymorphism in the serotonin transporter gene in a Japanese population.

    Alcohol Clin Exp Res 1999, 23:1281-1284. PubMed Abstract | Publisher Full Text OpenURL

  28. Schuckit MA, Mazzanti C, Smith TL, Ahmed U, Radel M, Iwata N, Goldman D: Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study.

    Biol Psychiatry 1999, 45:647-651. PubMed Abstract | Publisher Full Text OpenURL

  29. Nakamura M, Ueno S, Sano A, Tanabe H: The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants.

    Mol Psychiatry 2000, 5:32-38. PubMed Abstract | Publisher Full Text OpenURL

  30. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA: An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk.

    Alcohol Clin Exp Res 2005, 29:8-16. PubMed Abstract | Publisher Full Text OpenURL

  31. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, et al.: Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.

    Am J Hum Genet 2006, 78:815-826. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  32. Delbruck SJ, Wendel B, Grunewald I, Sander T, Morris-Rosendahl D, Crocq MA, Berrettini WH, Hoehe MR: A novel allelic variant of the human serotonin transporter gene regulatory polymorphism.

    Cytogenet Cell Genet 1997, 79:214-220. PubMed Abstract | Publisher Full Text OpenURL

  33. Gelernter J, Kranzler H, Cubells JF: Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects.

    Hum Genet 1997, 101:243-246. PubMed Abstract | Publisher Full Text OpenURL

  34. Kunugi H, Hattori M, Kato T, Tatsumi M, Sakai T, Sasaki T, Hirose T, Nanko S: Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder.

    Mol Psychiatry 1997, 2:457-462. PubMed Abstract | Publisher Full Text OpenURL

  35. Narita N, Narita M, Takashima S, Nakayama M, Nagai T, Okado N: Serotonin transporter gene variation is a risk factor for sudden infant death syndrome in the Japanese population.

    Pediatrics 2001, 107:690-692. PubMed Abstract | Publisher Full Text OpenURL

  36. Barnes NM, Sharp T: A review of central 5-HT receptors and their function.

    Neuropharmacology 1999, 38:1083-1152. PubMed Abstract | Publisher Full Text OpenURL

  37. Crabbe JC, Belknap JK, Buck KJ: Genetic animal models of alcohol and drug abuse.

    Science 1994, 264:1715-1723. PubMed Abstract | Publisher Full Text OpenURL

  38. Saudou F, Amara DA, Dierich A, LeMeur M, Ramboz S, Segu L, Buhot MC, Hen R: Enhanced aggressive behavior in mice lacking 5-HT1B receptor.

    Science 1994, 265:1875-1878. PubMed Abstract | Publisher Full Text OpenURL

  39. Crabbe JC, Phillips TJ, Feller DJ, Hen R, Wenger CD, Lessov CN, Schafer GL: Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors.

    Nat Genet 1996, 14:98-101. PubMed Abstract | Publisher Full Text OpenURL

  40. Cigler T, LaForge KS, McHugh PF, Kapadia SU, Leal SM, Kreek MJ: Novel and previously reported single-nucleotide polymorphisms in the human 5-HT(1B) receptor gene: no association with cocaine or alcohol abuse or dependence.

    Am J Med Genet 2001, 105:489-497. PubMed Abstract | Publisher Full Text OpenURL

  41. Fehr C, Grintschuk N, Szegedi A, Anghelescu I, Klawe C, Singer P, Hiemke C, Dahmen N: The HTR1B 861 G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy.

    Psychiatry Res 2000, 97:1-10. PubMed Abstract | Publisher Full Text OpenURL

  42. Lappalainen J, Long JC, Eggert M, Ozaki N, Robin RW, Brown GL, Naukkarinen H, Virkkunen M, Linnoila M, Goldman D: Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations.

    Arch Gen Psychiatry 1998, 55:989-994. PubMed Abstract | Publisher Full Text OpenURL

  43. Huang YY, Oquendo MA, Friedman JM, Greenhill LL, Brodsky B, Malone KM, Khait V, Mann JJ: Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism.

    Neuropsychopharmacology 2003, 28:163-169. PubMed Abstract | Publisher Full Text OpenURL

  44. Underwood MD, Mann JJ, Arango V: Serotonergic and noradrenergic neurobiology of alcoholic suicide.

    Alcohol Clin Exp Res 2004, 28:57S-69S. PubMed Abstract OpenURL

  45. Huang YY, Grailhe R, Arango V, Hen R, Mann JJ: Relationship of psychopathology to the human serotonin1B genotype and receptor binding kinetics in postmortem brain tissue.

    Neuropsychopharmacology 1999, 21:238-246. PubMed Abstract | Publisher Full Text OpenURL

  46. Kranzler H, Lappalainen J, Nellissery M, Gelernter J: Association study of alcoholism subtypes with a functional promoter polymorphism in the serotonin transporter protein gene.

    Alcohol Clin Exp Res 2002, 26:1330-1335. PubMed Abstract | Publisher Full Text OpenURL

  47. Gorwood P, Aissi F, Batel P, Ades J, Cohen-Salmon C, Hamon M, Boni C, Lanfumey L: Reappraisal of the serotonin 5-HT(1B) receptor gene in alcoholism: of mice and men.

    Brain Res Bull 2002, 57:103-107. PubMed Abstract | Publisher Full Text OpenURL

  48. Goldstein RB, Dawson DA, Saha TD, Ruan WJ, Compton WM, Grant BF: Antisocial behavioral syndromes and DSM-IV alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

    Alcohol Clin Exp Res 2007, 31:814-828. PubMed Abstract | Publisher Full Text OpenURL

  49. Ross HE, Glaser FB, Germanson T: The prevalence of psychiatric disorders in patients with alcohol and other drug problems.

    Arch Gen Psychiatry 1988, 45:1023-1031. PubMed Abstract | Publisher Full Text OpenURL

  50. Hesselbrock VM, Hesselbrock MN, Stabenau JR: Alcoholism in men patients subtyped by family history and antisocial personality.

    J Stud Alcohol 1985, 46:59-64. PubMed Abstract | Publisher Full Text OpenURL

  51. van den Bree MB, Svikis DS, Pickens RW: Genetic influences in antisocial personality and drug use disorders.

    Drug Alcohol Depend 1998, 49:177-187. PubMed Abstract | Publisher Full Text OpenURL

  52. Hwu HG, Yeh EK, Chang LY: Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule.

    Acta Psychiatr Scand 1989, 79:136-147. PubMed Abstract | Publisher Full Text OpenURL

  53. Endicott J, Spitzer RL: A diagnostic interview: the schedule for affective disorders and schizophrenia.

    Arch Gen Psychiatry 1978, 35:837-844. PubMed Abstract | Publisher Full Text OpenURL

  54. Huang SY, Lin WW, Ko HC, Lee JF, Wang TJ, Chou YH, Yin SJ, Lu RB: Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence.

    Alcohol Clin Exp Res 2004, 28:374-384. PubMed Abstract | Publisher Full Text OpenURL

  55. Goodwin RD, Hamilton SP: Lifetime comorbidity of antisocial personality disorder and anxiety disorders among adults in the community.

    Psychiatry Res 2003, 117:159-166. PubMed Abstract | Publisher Full Text OpenURL

  56. Hesselbrock V, Stabenau J, Hesselbrock M, Mirkin P, Meyer R: A comparison of two interview schedules. The schedule for affective disorders and Schizophrenia-Lifetime and the National Institute for Mental Health Diagnostic Interview Schedule.

    Arch Gen Psychiatry 1982, 39:674-677. PubMed Abstract | Publisher Full Text OpenURL

  57. Rogers R, Cunnien AJ: Multiple schedule of affective disorders and schizophrenia (SADS) in the assessment of criminal defendants.

    J Forensic Sci 1986, 31:222-230. PubMed Abstract OpenURL

  58. Maron E, Tammiste A, Kallassalu K, Eller T, Vasar V, Nutt DJ, Metspalu A: Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.

    Eur Neuropsychopharmacol 2009, 19:451-456. PubMed Abstract | Publisher Full Text OpenURL

  59. Wendland JR, Martin BJ, Kruse MR, Lesch KP, Murphy DL: Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531.

    Mol Psychiatry 2006, 11:224-226. PubMed Abstract | Publisher Full Text OpenURL

  60. Bowirrat A, Oscar-Berman M: Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome.

    Am J Med Genet B Neuropsychiatr Genet 2005, 132B:29-37. PubMed Abstract | Publisher Full Text OpenURL

  61. Faul F, Erdfelder E, Buchner A, Lang AG: Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses.

    Behav Res Methods 2009, 41:1149-1160. PubMed Abstract | Publisher Full Text OpenURL

  62. Faul F, Erdfelder E, Lang AG, Buchner A: G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.

    Behav Res Methods 2007, 39:175-191. PubMed Abstract | Publisher Full Text OpenURL

  63. Lyons-Ruth K, Holmes BM, Sasvari-Szekely M, Ronai Z, Nemoda Z, Pauls D: Serotonin transporter polymorphism and borderline or antisocial traits among low-income young adults.

    Psychiatr Genet 2007, 17:339-343. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  64. Reif A, Rosler M, Freitag CM, Schneider M, Eujen A, Kissling C, Wenzler D, Jacob CP, Retz-Junginger P, Thome J, et al.: Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment.

    Neuropsychopharmacology 2007, 32:2375-2383. PubMed Abstract | Publisher Full Text OpenURL

  65. Sadeh N, Javdani S, Jackson JJ, Reynolds EK, Potenza MN, Gelernter J, Lejuez CW, Verona E: Serotonin transporter gene associations with psychopathic traits in youth vary as a function of socioeconomic resources.

    J Abnorm Psychol 2010, 119:604-609. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  66. Lu RB, Lee JF, Huang SY, Lee SY, Chang YH, Kuo PH, Chen SL, Chen SH, Chu CH, Lin WW, et al.: Interaction between ALDH2*1*1 and DRD2/ANKK1 TaqI A1A1 genes may be associated with antisocial personality disorder not co-morbid with alcoholism.

    Addict Biol OpenURL

  67. Baumgarten HG, Grozdanovic Z: Psychopharmacology of central serotonergic systems.

    Pharmacopsychiatry 1995, 28(Suppl 2):73-79. PubMed Abstract | Publisher Full Text OpenURL

  68. Parsons LH, Weiss F, Koob GF: Serotonin1b receptor stimulation enhances dopamine-mediated reinforcement.

    Psychopharmacology (Berl) 1996, 128:150-160. Publisher Full Text OpenURL

  69. Walsh SL, Cunningham KA: Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine.

    Psychopharmacology (Berl) 1997, 130:41-58. Publisher Full Text OpenURL

  70. Hallbus M, Magnusson T, Magnusson O: Influence of 5-HT1B/1D receptors on dopamine release in the guinea pig nucleus accumbens: a microdialysis study.

    Neurosci Lett 1997, 225:57-60. PubMed Abstract | Publisher Full Text OpenURL

  71. Yadid G, Pacak K, Kopin IJ, Goldstein DS: Endogenous serotonin stimulates striatal dopamine release in conscious rats.

    J Pharmacol Exp Ther 1994, 270:1158-1165. PubMed Abstract | Publisher Full Text OpenURL

  72. Cesura AM, Pletscher A: The new generation of monoamine oxidase inhibitors.

    Prog Drug Res 1992, 38:171-297. PubMed Abstract OpenURL

  73. Keung WM, Vallee BL: Daidzin: a potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase.

    Proc Natl Acad Sci U S A 1993, 90:1247-1251. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  74. Wang TJ, Huang SY, Lin WW, Lo HY, Wu PL, Wang YS, Wu YS, Ko HC, Shih JC, Lu RB: Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan.

    Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:108-114. PubMed Abstract | Publisher Full Text OpenURL

  75. Goldman N, Glei DA, Lin YH, Weinstein M: The serotonin transporter polymorphism (5-HTTLPR): allelic variation and links with depressive symptoms.

    Depress Anxiety 2010, 27:260-269. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL